Current Investments
Current Investments
 

MedeAnalytics is a leading enterprise analytics solutions provider for health systems and health plans. The company’s SaaS-based platform enables organizations to make even smarter decisions with data, with advanced data orchestration that delivers scalable, purpose-built, and state-of-the-art analytics. MedeAnalytics supports more than 2,000 healthcare organizations across the U.S. and internationally, providing actionable insights that drive measurable, tangible value across revenue cycle management, value-based performance, cost and operations, payer operations, and broker and employer group engagement.

INVESTMENT STRATEGY

Uniquely Scaled and Sophisticated Platform: Dedicated exclusively to healthcare, MedeAnalytics was the first to market in 1994 with a healthcare analytics SaaS solution. Having served blue chip healthcare organizations for nearly three decades, the company has deep expertise in developing and delivering technology in complex environments, serving critical and continuously evolving needs across business functions. That spirit of innovation continues today, with a platform that integrates advanced analytics technologies like machine learning, guided analysis, and predictive analytics.

Clear and Actionable Growth Plans: JLL partnered with MedeAnalytics to further enhance its comprehensive offering by adding complementary capabilities, both organically and through strategic M&A. Together we’ve identified multiple value creation levers that could optimize the company’s performance and positioning, including investments to augment the technology infrastructure, customer service, and go-to-market process. To this end, JLL has brought to bear its longstanding industry experience and network of resources, including recruiting and appointing world-class executives to join the Board of Directors.

Visit MedeAnalytics